HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Marina Ramirez-Alvarado Selected Research

Immunoglobulin Light Chains (Immunoglobulin Light Chain)

1/2020Light chain amyloidosis induced inflammatory changes in cardiomyocytes and adipose-derived mesenchymal stromal cells.
1/2019Mechanistic Insights into the Early Events in the Aggregation of Immunoglobulin Light Chains.
9/2018Immunoglobulin light chain amyloid aggregation.
12/2017Mesenchymal stromal cells protect human cardiomyocytes from amyloid fibril damage.
6/2017Assessment of renal response with urinary exosomes in patients with AL amyloidosis: A proof of concept.
1/2017Solid-state NMR chemical shift assignments for AL-09 VL immunoglobulin light chain fibrils.
1/2017Differences in Protein Concentration Dependence for Nucleation and Elongation in Light Chain Amyloid Formation.
1/2016Recruitment of Light Chains by Homologous and Heterologous Fibrils Shows Distinctive Kinetic and Conformational Specificity.
1/2016Cell Damage in Light Chain Amyloidosis: FIBRIL INTERNALIZATION, TOXICITY AND CELL-MEDIATED SEEDING.
12/2015Thermodynamic and fibril formation studies of full length immunoglobulin light chain AL-09 and its germline protein using scan rate dependent thermal unfolding.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Marina Ramirez-Alvarado Research Topics

Disease

30Amyloidosis
06/2021 - 07/2006
26Immunoglobulin Light-chain Amyloidosis
01/2021 - 09/2008
12Amyloid Plaque
01/2021 - 07/2006
8Proteostasis Deficiencies
12/2017 - 01/2009
6Multiple Myeloma
11/2017 - 01/2008
4Alzheimer Disease (Alzheimer's Disease)
05/2012 - 07/2006
3Neoplasms (Cancer)
12/2020 - 03/2007
2Paraproteinemias (Monoclonal Gammopathy)
12/2012 - 03/2009
1Vesicular Stomatitis
12/2020
1Transthyretin-Related Hereditary Amyloidosis
11/2020
1Plasma Cell Neoplasms
01/2020
1Immunoproliferative Disorders
01/2017
1Polycystic Kidney Diseases (Polycystic Kidney Disease)
01/2017
1Residual Neoplasm
01/2016
1Cardiomyopathies (Cardiomyopathy)
01/2015
1Autoimmune Diseases (Autoimmune Disease)
11/2014
1Albuminuria
12/2012
1Necrosis
12/2012
1Kidney Diseases (Kidney Disease)
12/2012
1Dementia (Dementias)
05/2012
1Monoclonal Gammopathy of Undetermined Significance
01/2012
1Disease Progression
09/2010
1Hemolysis
08/2009
1Neurodegenerative Diseases (Neurodegenerative Disease)
07/2007

Drug/Important Bio-Agent (IBA)

30Amyloid (Amyloid Fibrils)IBA
11/2020 - 07/2006
25Immunoglobulin Light Chains (Immunoglobulin Light Chain)IBA
01/2020 - 07/2006
20Proteins (Proteins, Gene)FDA Link
06/2021 - 06/2008
5Immunoglobulins (Immunoglobulin)IBA
02/2017 - 01/2008
2Immunoglobulin M (IgM)IBA
01/2021 - 01/2020
2AntigensIBA
12/2020 - 07/2007
2GlycosaminoglycansIBA
02/2015 - 09/2011
2PolyaminesIBA
08/2008 - 07/2007
2Immunoglobulin FragmentsIBA
08/2008 - 07/2007
1Cancer VaccinesIBA
12/2020
1Neoplasm Antigens (Tumor Antigens)IBA
12/2020
1Keratins (Keratin)IBA
11/2020
1Complement System Proteins (Complement)IBA
11/2020
1ProteomeIBA
11/2020
1Contractile ProteinsIBA
11/2020
1Amino AcidsFDA Link
09/2018
1florbetapirIBA
01/2017
1Extracellular Matrix ProteinsIBA
01/2017
1Brain Natriuretic Peptide (Natrecor)FDA Link
01/2017
1Peptides (Polypeptides)IBA
01/2016
1AlbuminsIBA
12/2012
1Glutamic Acid (Glutamate)FDA Link
05/2012
1PolymersIBA
09/2011
1Hemolysin Proteins (Hemolysins)IBA
08/2009
1GadoliniumIBA
08/2008
1gadolinium 1,4,7,10- tetraazacyclododecane- N,N',N'',N'''- tetraacetateIBA
08/2008
1EmulsionsIBA
08/2008
1Chelating AgentsIBA
08/2008
1Contrast MediaIBA
07/2007
1Radioisotopes (Radionuclides)IBA
07/2007
1Monoclonal AntibodiesIBA
07/2007
1Immunoglobulin G (IgG)IBA
07/2007
1Tumor Suppressor Protein p53IBA
03/2007
1PutrescineIBA
07/2006

Therapy/Procedure

2Immunotherapy
01/2017 - 07/2007
2Intravenous Injections
08/2008 - 07/2007
1Aftercare (After-Treatment)
11/2013